SVRA Competitors & Alternatives
Compare Savara Inc with similar stocks in the same industry
Biotechnology
SVRA
Main Stock$5.34
Tradestie Score
60
Market Cap
$611.84M
Analyst Upside
+104.8%
Top Competitors
222 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ELVN
Enliven Therapeutics, Inc. Common Stock
|
$42.33
|
$1.17B | - | 57 | Compare |
|
INVA
Innoviva, Inc. Common Stock
|
$22.60
|
$1.15B | 3.6 | 62 | Compare |
|
TRVI
Trevi Therapeutics, Inc. Common Stock
|
$14.55
|
$1.14B | - | 59 | Compare |
|
ORIC
Oric Pharmaceuticals, Inc. Common Stock
|
$8.24
|
$1.14B | - | 59 | Compare |
|
MAZE
Maze Therapeutics, Inc. Common Stock
|
$24.04
|
$1.13B | - | 51 | Compare |
|
WVE
Wave Life Sciences Ltd. Ordinary Shares
|
$5.92
|
$1.12B | - | 54 | Compare |
|
NKTR
Nektar Therapeutics
|
$60.64
|
$1.12B | - | 52 | Compare |
|
PRAX
Praxis Precision Medicines, Inc. Common Stock
|
$265.15
|
$1.12B | - | 55 | Compare |
|
IMTX
Immatics N.V. Ordinary Shares
|
$9.41
|
$1.09B | - | 52 | Compare |
|
PHAR
Pharming Group N.V. ADS, each representing 10 ordinary shares
|
$12.82
|
$1.05B | 67.8 | 55 | Compare |
More SVRA Analysis
Data updated: Jun 15, 2026 | Industry: Biotechnology (SIC 2834)
222 stocks in this industry